Therefore, to address this hypothesis, the TNFRSF1B, TNFRSF9, and BCL2 promoters were cloned and sequenced (Supplementary Figure S7), and a dual-luciferase reporter assay system was used to analyze their activities in BC cells. The gene discussed is TNFRSF9; the disease is breast cancer.